Nutraceuticals in Paediatric Patients with Dyslipidaemia

Nutraceuticals in Paediatric Patients with Dyslipidaemia

Coronary heart disease (CHD) is the main cause of death and morbidity in the world. Childhood is a critical period during which atherosclerosis may begin to develop; in the presence of familial hypercholesterolaemia (FH), the lifelong elevation of LDL cholesterol levels greatly accelerates atheroscl...

Full description

Bibliographic Details
Main Authors: Giuseppe Banderali, Maria Elena Capra, Claudia Viggiano, Giacomo Biasucci, Cristina Pederiva
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Nutrients
Subjects:
nutraceuticals
paediatric
diet
familial hypercholesterolaemia
dyslipidaemia
Online Access:https://www.mdpi.com/2072-6643/14/3/569

Internet

https://www.mdpi.com/2072-6643/14/3/569

Similar Items